Trump’s Latest Executive Order Will Impact the FDA
In his first week in office, President Donald Trump has signed 7 executive orders, and the most recent order requires that agencies eliminate 2 regulations for each new one created. According to the Regulatory Affairs and Professionals Society, this “1 in, 2 out” plan is expected to impact the heavily regulated FDA, but the exact extent is still unknown. The order seems to apply to guidance documents, as well as regulations, which may cause confusion among medical device and pharmaceutical companies.
Vaccine Advocates Mobilize
With increasing threats to public health from vaccine skeptics, proponents of vaccinations are stepping up to advocate for the benefit that vaccines have for public health. Advocates see the biggest threat coming from the president himself, who has expressed doubts about the safety of vaccines, has met with antivaccine advocates, and has shown interest in having Robert F. Kennedy Jr (an outspoken vaccine critic) chair a commission on vaccine safety, reported STAT. An advocacy group for vaccines has seen an increase in membership, and advocates have the support of former First Lady Rosalynn Carter.
Short-Term Health Insurance May Increase With ACA Repeal
While short-term health insurance plans have been around for decades, their popularity is expected to increase as Republicans work to weaken and repeal the Affordable Care Act (ACA), according to Kaiser Health News. Short-term plans include a lot of practices that were prohibited in qualified health plans under the ACA, but as a result, they had much cheaper premiums. From 2013 to 2015, the number of people enrolled in short-term plans increased 36%.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More
Risk for Second Primary Melanoma Increases After Primary Melanoma Diagnosis as Men Age
March 28th 2024A population-based cohort study out of Norway has found that older men have a higher risk of developing second primary invasive melanoma following an initial primary melanoma, suggesting the benefits of increased surveillance in these patients.
Read More